Evaluation of thyroid nodules classified as Bethesda category III on FNAC
Background: The Bethesda (BSRTC) category III has been ascribed a malignancy rate of 5-15%, however, the probability of malignancy remains variable. Aim: To evaluate category III with respect to its rate and risk of malignancy and substratify it. Settings and Design: Atypia of undetermined signifi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Journal of Cytology |
Subjects: | |
Online Access: | http://www.jcytol.org/article.asp?issn=0970-9371;year=2017;volume=34;issue=1;spage=5;epage=9;aulast=Garg |